Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Number of shares is all relevant to the investors personal situation.
Also, IPIX being so high risk (at least up to about 3-4 months ago) I consider anybody invested in it was pretty much all in (unless they only held 5-10K shares).
I know of some with 30K shares and it is a monster investment for them.
I know of many in the six figure range (from 100K to 950K) and they all consider their positions as large, many extremely large.
I also know quite a number in the 7 figure range and some of these are in much deeper than their financial condition would consider prudent, but they to a person believe 100% in the science of B and K and the success of the company.
I don't look at the number of shares, I would consider instead where IPIX ranks in your portfolio of stocks as to whether it is a major investment or not.
Bottom line: I have much more respect for those that have little and have wagered much on the success of IPIX as compared to a rich person that has a lot of shares but whose overall financial situation will not be changed even if it fails.
In that regard, I question EVERYONE who is on this board 24/7 - whether they be a pro or con IPIX poster.
There has to be some reason they are here so much (as in being paid)
Even those with large positions don't watch this board constantly.
Just sayin'
Some may say I am here too much - if so, take all I say with a grain of salt.
But, but, but..... we have been told there are no games being played on IPIX, no nefarious hooligans, no naked shorting.
How can this be? (heavy on the sarcasm)
Perfect example of different investing aims:
Snackman wants a good return but with little risk
Tamtam wants BIG returns and willing to take many risks
Could be simply a difference in risk tolerance or financial situations, those of us down in the pennies looking for riches while those with a strong current financial position are looking to only solidify their financial status. It is why we don't see institutions and financial funds investing in penny stocks.
This is what makes this board so broad-based in opinions - different end zones, different games, etc.
All perfectly acceptable.
From the FCCDC website:
http://www.fc-cdci.com/PressReleases/2018-09-05_DoD.html
IMO, this has to show some advancement has been shown by FCCDC regarding work into B-Fungal for them to have come to commercialization terms of payment. May have a bit more legs than what one would think at first blush.
Look for it at about the same time as end of fiscal year is 30 June so they have 3 months to get the 10K out.
I don't believe that is the case.
Brilacidin, and the data published to date, are too strong to now try and bury.
BIG,BIG stink could be thrown at those currently running the CV program which at this time they don't need.
CV19, BLM, city shut downs, rioting, etc are all political IMO and if some group could find a solution (enter Brilacidin) they are going to look mighty, mighty good.
I am TOTALLY against any deal with Gilead for a CV19 cocktail!!
Why?
Even at the expense to IPIX shareholders, a cocktail that includes Rems.... IMO is nothing but another pig wallowing up to the Federal money trough at the expense of the general public (and not just the American public, the WORLD public)
I think most here will agree Rems.... adds NOTHING to Brilacidin in fighting CV19 - at the most, what, maybe 1-2% and I don't even believe it would provide that much of an improvement.
Yet the costs for such treatment would soar compared to a treatment comprised solely of Brilacidin.
Many on this board have said how proud they were to be involved with a company to benefit mankind. Well, now is the time to put up or shut up.
If IPIX goes w/ Gilead for the $$$$, we are no better than BP wallowing up to the trough.
Brilacidin is going to make shareholders more than enough money, we don't need to stick it to the world for CV19 treatment.
Same here, I got the last laugh though as my wife is now ashamed she had me have the tattoo "DUMBA**" put on my back years ago.
All we are asking is that the media report FINDINGS, actual data from RBL investigating trials. No opinions, recommendations, etc just report FINDINGS.
I am sure you could request it but not sure that you would get it; not only for short term lack of product but also if they gave it to one they would have to try and give it to all that wanted it and that couldn't be handled.
Also, would IPIX want to chance it? Had a neighbor whose sister was in a trial for a melanoma drug that appeared to be working wonderfully. She developed some arrhythmic heart indications and was immediately thrown out of the trial. She died weeks later as she went downhill fast once she stopped taking the drug.
The drug company explained that if she died during the trial and they had any indication her heart problem was due to the drug, it would set the company back at least 7 years in trials. They were sorry for her fate, but they couldn't chance the drug being off the market that long and the company most likely folding.
Thus, would IPIX take the chance even if they had the IV?
This situation is known to everybody on down from Congress, Wall St, SEC, FINRA, and anybody else that makes money from the stock market. They aren't going to kill the golden goose.
It is kind of like the "term limits" for Congress in the financial world. Everyone knows it is needed, but those with the power are the ones making the rules and the money. Ain't gonna end.
From the results of the data given so far, it doesn't appear the human trial has to be that picky of selecting "ideal" candidates as it should work on 95% of patients or so.
Losing sight of the forest for the trees, we need a treatment now and a human trial with a safe dose (not necessarily the least or the highest dosage tested) to get a general overview as to whether B is going to work or not.
Once the above is established, the trial can be refined to perfect the dosage, # of treatments, etc but we have the patients needing something now having a glimmer of hope and a much, much higher chance of pulling thru their ordeal.
Is it standard on Wall St that filings get much more attention than do PRs from the companies?
How could the RBL say anything about Rems.... if they were not the ones who did the testing on Rems.....? I assume most of Rems... was done at a private lab since they are part of a BP.
Commercial concerns may be able to give their opinions, but RBLs are pretty much confined to just reporting what they actually saw in their own investigations and trials.
Standard Boilerplate PR response IMO. Who knows if it only means throwing in the trash or actually going to take a look? I wouldn't put much weight behind it.
Take all with a grain of salt (a large grain)
I think what you are seeing now is part of the results from the $35K IPIX paid the RMU RBL researcher to do further testing on B. We knew we got a steal on the price for the research, now we get a fortune dropped in our lap from the acquired data.
The Headline screams it:
July 20, 2020
Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the LOWEST CONCENTRATION TESTED TO DATE IN A HUMAN LUNG CELL LINE.
1 Does this headline mean to imply Brilacidin is the ONLY drug to date that has undergone human lung testing and the dosage at our 95% effective rate was the prior lowest concentration?
2 If not, then Rems... had the lowest concentration level and they went down to 50% effective.
3 Brilacidin tested at that same LOWEST concentration and maintained a 90% effective rate.
4 How low can Brilacidin go to only have to reach 50% effective rate?
5 As the dosage concentration drops, the SI ratio rises so Brilacidin is assured of a monstrously high SI number.
IMO
It should be apparent to anyone reading the article that Brilacidin really does not need Rems.... at all. Just give a slightly higher dose of B and you get nearly 100% viral load reduction.
First off, why pay for Rems... in a cocktail as it is expensive and is contributing next to nothing?
Secondly, IPIX likely put Rems..../Gilead in the PR so as to capture all the eyes that have alerts in place for any article mentioning them. Great way to spread our Brilacidin success to the many, many eyes following Gilead. This idea was mentioned in a prior post by someone on this board and I thought it highly appropriate.
One area in which this news should help the SP is that most investors will be hesitant to trade their shares so easily. Hands getting a little tighter and that should send the SP up IMO.
Should also get the attention of some larger players.
Those on the wrong side of a trade now are sweating bullets.
You would think Gilead would run the combo tests (at their expense) since they with their 50% and us with our 90% effective rate shows that their drug is the one that appears to be tagging along our coattails.
Potential now for IPIX/Brilacidin to finally get the major publicity push we have been waiting for - not guaranteed, but looking like a very good chance.
If you are talking about B, you don't want a capsule that breaks down in the stomach and threatens all the good probiotics. For CV, I would assume they want it to break down in the small intestine. Is that doable or do they need a BDD time release pill made to dissolve in the small intestine to do that?
Not a medical person, may be way off base here.
What a relief to hear that a medical professional has the same viewpoints as do I in regards to getting Brilacidin into actual patients NOW and the apparent lack of awareness of Brilacidin throughout the CV19 hierarchy of administrators.
In your opinion, after the results came in from the RBLs in regards to the lung and kidney tissue investigations AND the PAN-CORONA request by the RBL (in conjunction with IPIX) due to obvious positive results (or at least expectations) in regards to encephalitic and filo viruses, do you think Brilacidin should have been taken out of the general mill of all drugs being considered and put in to a separate category of possible MAJOR treatment stars?
I hope I am not just showing an "investor" bias but Brilacidin and all its scientific pluses seems to scream to those in charge to handle it differently, quickly, and thoroughly.
No clue as to whether IPIX/Brilacidin was discussed.
But if it wasn't, I think there would be a good case that somebody should be brought up on criminal charges.
The grant request has been in for weeks, the data is stellar and even a non-medical person can see the advantages that Brilacidin has over all other drugs we have been shown to date as possible candidates for CV19 effectiveness, and a delay now will definitely, not probably, result in many, many deaths worldwide and the crumbling of economies across the globe. IMO Brilacidin should have been the first item on the agenda today and even if they didn't get to other grant requests, reschedule those for another time. When a baseball team is evaluating prospects, they don't bury the #1 prospect until late in the meeting (As I read this I realize I am way over the top - but Brilacidin should be recognized as a star potential treatment and given that degree of respect by the committee)
The whole panel today was made up of microbiologists, those who will be able to recognize the strengths, advantages, and overall possibilities of Brilacidin for CV and many other medical conditions. Was that just coincidence? Hope not.
I cannot think of a single scenario where the panel today isn't overwhelmed by the data provided by the RBLs. They have to be presenting much more data than we have been privy to as they went for a PAN-CORONA investigation, and to do that we know they had to have seen lots to get their attention, at the least the anti-inflammatory properties for brain conditions and the possibility B may work on filo viruses. I tend to believe they saw more than that and have seen additional results just within the last couple of weeks.
I understand being conservative, but when you are placing a bet on a game between a professional football team and a high school team, the result is overwhelmingly apparent. IMO same with our grant request.
We also have prior clinical trials showing Brilacidin transfers test data into human trials quite well. In this regard, I agree there is always a chance something goes wrong, but I sure like our chances.
Very happy with today's trading.
Expect grant review today went really well (how could it not with the data collected to date?)
I DO NOT expect news to be forthcoming next week on results of the grant mtg - have never seen govt move that fast, especially when doling out big bucks (so of course some big news will probably come out) but I do believe we get some strong news by end of the month and much more by end of Aug and Sept.
I think by end of the year we could be $5 to way over $5. Brilacidin should be a household name by then IMO.
With B and K, I do believe IPIX is on the verge of becoming a small BP in its own right, just like Regeneron.
Lots of new names recently, have to believe lots of wolves in sheep's clothing among them.
Remember, NOBODY knows ANYTHING regarding secret data. What was talked about this week was a notice of public record, it just wasn't that apparent to most people. If anybody tries to peddle inside info as to awards granted, date of information release, workings Leo has procured for the company, manufacturing of B, etc, etc is all just pure conjecture. Don't take anything at face value as those that might have inside info surely are not going to spill it on a public message board. Think about that, if you had some good inside info would you share it with the world so as to dilute the value of it?
That pretty well sums up what most longs feel about IPIX.
Thanks
Just wondering, how did your amount of investment in Qualcomm stack up against your current investment in IPIX? Not so much in terms of dollars but in degree of your overall investing portfolio - who did you think had/has a better opportunity for success and how did you expectations for ROI compare with QC prior to them taking off compared to how you feel now regarding IPIX expectations and ROI?
I strongly support your position.
Tomorrow will be a great day at the grant meeting IMO, but I doubt we hear about it even next week. Sometime soon, but not that soon.
Think the hype was done to try and make it look Monday like things went wrong during the grant mtg and trading groups will most likely try and shake more shares out of weak hands.
Might see some weakness late tomorrow for those wanting to flip a few shares for a few pennies, but IMO those of us with our boats loaded are not trading this close to possible good news.
Most brokerages I ever used considered all transactions for a specific trade on any one day as one trade and only charged once. If your brokerage is screwing you with multiple charges for the same trade on the same day, change brokerage. They aren't doing you any favors.
I had a brokerage once that would automatically trade 10 shares immediately and then nothing would trade the rest of the day. Didn't last long with them, either, as just another money gouging ploy. Too many decent brokerages to stay with a shyster.
I believe the INH knows what they have in Brilacidin from input received from their 2 RBLs investigating B to date. They are also aware one wants to do a full PAN-CORONA investigation for a multitude of additional uses of B. As part of the IPIX PR dtd 13 July, IPIX stated "the Company has drafted a study protocol toward initiating a planned Phase 2 trial of Brilacidin for COVID-19. This proposed study has two active treatment arms evaluating different IV dosing regimens in hospitalized patients with COVID-19."
What the above means is that already there is a pretty defined dosage level to be tested in the human trial and without a doubt a human trial will be forthcoming for Brilacidin.
We are in a war against CV. As such, prior to a full scale invasion or operation you need to send in special forces to give you a better idea of what you will be facing. No different in the fight against CV19.
Powers to be IMO should IMMEDIATELY implement a secret human trial on say 30-40 patients in a govt hospital (say Walter Reed right next door to DC area), use govt/military personnel infected w/ CV19 who voluntarily take the drug to see how it works on say 20 people with preliminary symptoms and the other 20 with severe symptoms. At the WORST, the drug will have no effect, there will be no patients put in danger based on Brilacidin prior results in ABSSSSI trial. All that is needed is 40 units of B-IV (or maybe 80 so they get 40 at each dosage level). They would have results within 3-4 days if B-IV works as quickly as it showed in vitro and in veno testing. This small trial has no downside that I can see but extremely large upside potential.
That would give the govt a much faster response time to ramp up both production of the IVs, make the large scale human trial that much more focused, and allow them to see if Brilacidin should be granted VAST amounts of money to be tried on the entire range of corona, filo, encephalitic, HIV, and any other viruses they think on which it would work.
Break the mold of slow, slow, slow and get the ball rolling.
If this small trial doesn't work out well, they wouldn't have to tell anyone as nobody would know what drug had been given to the patients or that any such trial had ever taken place.
Not legal shorting, "naked" shorting. Illegal means that the current trading system allows to MMs, hedge funds, etc to take down start ups usually with ease.
that is why all the talk to change from a T+2 system to a T+0 system(a chain block system)
google overstock corp and see what happened to them; happens to a lot more besides
I wasn't speaking of peer review for this grant, there isn't any peer review to date on IPIX tests, but data coming from RBL labs should be accorded higher factual basis IMO than private labs for profit.
Read my edited post again.
No, there is a closed meeting from a valid CV19 committee meeting Fri to discuss grant requests. We know the location (near DC), we know the time, but that is about it.
As to why I think IPIX is on the agenda, joint grant applier is an INH Regional Bio Lab and the committe is an INH committee. If they don't move their own labs to the head of the line and give those labs credit for knowing what the hell they are doing and having the expertise to perform the investigating trials correctly, then they have a real problem.
That is why I believe the peer reviewed articles are given too much importance. If a private lab submitted data, I believe it should be put thru the wringer as to validity. But if a government lab set up to combat viral/bacterial threats submits the data, that should be as good as gold.
When you are given info with stipulations, you follow same or you get out of the loop of getting info. Have you secured any sources that give you some good leads from time to time? I have and I keep them by playing by their rules. They are friends, not secret agents trying to screw anyone.
If you have followed this stock for over a week, it is apparent nothing can be said here that isn't going to be spun by those wishing the company goes down the tubes. There is plenty known that can't be put on this forum for that reason.
If you don't like what we said, relate the info to the trash bin. If you want info that is not privy to the masses for whatever reason (maybe someone just in the right place at the right time) then take what is given with a grain of salt and keep quiet.
We aren't trying to be jackasses, we are just following the wishes of those that contact us with info.
Radio Wreck is posting the truth. There is a mtg Fri 10-5:30 to discuss grants. Whether IPIX is one of the grants being discussed is not known. But since the mtg was set in mid-June one would assume all grant requests between then and now would be on the agenda. Not guaranteed, but IMO probable.
Committee from INH. This is the obvious place an RBL would submit a grant as they are part of the INH. This is the grant that was submitted in June with IPIX for the PAN-CORONA monies.
Barda grant was submitted in Feb to Barda.
Like Radio, I was given the info with specific instructions only to pass on to true longs. As such, cannot post it on open board. I will pass on to a trusted few Fri during Happy Hour if any of them contact me to do so.
Does anyone believe there is a chance in hell it will be turned down? I don't think so.
No word as to when awards will be PRd, so those saying something Monday are just throwing out a hunch and possibly setting up IPIX for a takedown should no word appear.
Bottom line is that things are moving quicker possibly than many were giving IPIX credit just a couple of days ago.
To date I believe somebody posted that Brilacidin has been found effective against 90 lines of bacteria, or thereabouts, and has not met a bacterial strain it couldn't kill.
If it proves to be as effective against most lines of viruses (and the PAN_CORONA grant request by the RBL gives a strong indication it might) as it has proven against bacteria then Brilacidin will definitely have a strong case to be considered maybe the most important drug ever developed.
Think about that, a chance for becoming the best drug ever in terms of scope of medical areas it could affect.
And the grandest point of all: IPIX isn't making these ascertains, government labs and clinical trials have derived all the data to date. How could anybody not believe in the science of Brilacidin?
I have been hammering the point that a drug formulated via artificial intelligence compared to the old way of a BP trying to formulate it in a lab with 10-100 scientists is like comparing a Ferrari to a Model T.
We have the goods. All we need is time (like to the end of the year) for the world to understand this.
But like THE LORD OF THE RINGS, we are going to have to go thru more pretty bumpy times (in terms of share price) until we finally bring down the followers of doom. Don't let the daily price gyrations or even possible price compression wear you down or lose confidence in the end result.
That is why I said this morning that I thought this was the last PR (along with the S-3 filing Friday PR) anybody could try to spin as a negative. Any surprise in the future I see only to the positive side.